Sangamo Therapeutics Inc (SGMO)

9.42 -0.04  -0.37% NASDAQ Nov 15, 10:42 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/07/2020 12:30 EST Misc Sangamo Therapeutics Inc Fourth Quarter Earnings Conference Call in 2019
02/07/2020 Earnings Sangamo Therapeutics Inc Fourth Quarter Earnings in 2019 Release
11/06/2019 17:00 EST Misc Sangamo Therapeutics Inc Third Quarter Earnings Conference Call for 2019
11/06/2019 Earnings Sangamo Therapeutics Inc Third Quarter Earnings in 2019 Release
08/07/2019 17:00 EDT Misc Sangamo Therapeutics Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Sangamo Therapeutics Inc Second Quarter Earnings in 2019 Release
06/10/2019 09:00 PDT Misc Sangamo Therapeutics Inc Annual General Meeting in 2018
05/08/2019 Earnings Sangamo Therapeutics Inc First Quarter Earnings in 2019 Release
05/08/2019 17:00 EDT Misc Sangamo Therapeutics Inc First Quarter Earnings Conference Call in 2019
03/01/2019 Misc Sangamo Therapeutics Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.sangamo.com
  • Investor Relations URL: http://investor.sangamo.com/index.cfm
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 07, 2020
  • Last Earnings Release: Nov. 06, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Top Fund Holders

Symbol Name Weighting
CIG4924 CI Global Health Sciences Corp Cl Y 2.94%
F000011I5D FT SMid Biotechnology Portfolio 4 CA 2.18%
GNOM Global X Genomics & Biotechnology ETF 2.14%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 1.46%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.